Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline
Top Cited Papers
- 15 December 2004
- journal article
- guideline
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (24) , 4979-4990
- https://doi.org/10.1200/jco.2004.11.032
Abstract
The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers are risk-based, exposure-related clinical practice guidelines intended to promote earlier detection of and intervention for complications that may potentially arise as a result of treatment for pediatric malignancies. Developed through the collaborative efforts of the Children’s Oncology Group Late Effects Committee, Nursing Discipline, and Patient Advocacy Committee, these guidelines represent a statement of consensus from a multidisciplinary panel of experts in the late effects of pediatric cancer treatment. The guidelines are both evidence-based (utilizing established associations between therapeutic exposures and late effects to identify high-risk categories) and grounded in the collective clinical experience of experts (matching the magnitude of risk with the intensity of screening recommendations). They are intended for use beginning 2 or more years following the completion of cancer therapy; however, they are not intended to provide guidance for follow-up of the survivor’s primary disease. A complementary set of patient education materials (“Health Links”) was developed to enhance follow-up care and broaden the application of the guidelines. The information provided in these guidelines is important for health care providers in the fields of pediatrics, oncology, internal medicine, family practice, and gynecology, as well as subspecialists in many fields. Implementation of these guidelines is intended to increase awareness of potential late effects and to standardize and enhance follow-up care provided to survivors of pediatric cancer throughout the lifespan. The Guidelines, and related Health Links, can be downloaded in their entirety at www.survivorshipguidelines.org .Keywords
This publication has 41 references indexed in Scilit:
- High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study GroupJournal of Clinical Oncology, 2003
- Health Issues in Survivors of Childhood CancerSouthern Medical Journal, 2002
- Breast Cancer Screening in Women Previously Treated for Hodgkin’s Disease: A Prospective Cohort StudyJournal of Clinical Oncology, 2002
- Abnormalities of the Thyroid in Survivors of Hodgkin's Disease: Data from the Childhood Cancer Survivor StudyJournal of Clinical Endocrinology & Metabolism, 2000
- Breast Cancer After Treatment of Hodgkin's DiseaseJNCI Journal of the National Cancer Institute, 1993
- Thyroid function after treatment of brain tumors in childrenThe Journal of Pediatrics, 1991
- Long-term endocrine sequelae after treatment of medulloblastoma: Prospective study of growth and thyroid functionThe Journal of Pediatrics, 1986
- Serial thyroid function measurements in children with Hodgkin diseaseThe Journal of Pediatrics, 1984
- Thyroid dysfunction after radiotherapy in children with Hodgkin's diseaseCancer, 1984
- Thyroid function in pediatric patients after neck irradiation for Hodgkin diseaseMedical and Pediatric Oncology, 1980